nodes	percent_of_prediction	percent_of_DWPC	metapath
Benzphetamine—CYP3A4—Salbutamol—chronic obstructive pulmonary disease	0.138	0.282	CbGbCtD
Benzphetamine—CYP3A4—Tiotropium—chronic obstructive pulmonary disease	0.0935	0.19	CbGbCtD
Benzphetamine—CYP3A4—Aminophylline—chronic obstructive pulmonary disease	0.0892	0.182	CbGbCtD
Benzphetamine—CYP3A4—Montelukast—chronic obstructive pulmonary disease	0.0795	0.162	CbGbCtD
Benzphetamine—CYP3A4—Prednisolone—chronic obstructive pulmonary disease	0.0466	0.0949	CbGbCtD
Benzphetamine—CYP3A4—Prednisone—chronic obstructive pulmonary disease	0.044	0.0896	CbGbCtD
Benzphetamine—Tremor—Roflumilast—chronic obstructive pulmonary disease	0.00667	0.0226	CcSEcCtD
Benzphetamine—Palpitations—Roflumilast—chronic obstructive pulmonary disease	0.00629	0.0213	CcSEcCtD
Benzphetamine—Trimethaphan—CHRNA3—chronic obstructive pulmonary disease	0.00573	0.225	CrCbGaD
Benzphetamine—Insomnia—Roflumilast—chronic obstructive pulmonary disease	0.00525	0.0178	CcSEcCtD
Benzphetamine—Dyspepsia—Roflumilast—chronic obstructive pulmonary disease	0.00511	0.0173	CcSEcCtD
Benzphetamine—Decreased appetite—Roflumilast—chronic obstructive pulmonary disease	0.00505	0.0171	CcSEcCtD
Benzphetamine—Gastrointestinal disorder—Roflumilast—chronic obstructive pulmonary disease	0.00501	0.017	CcSEcCtD
Benzphetamine—Urticaria—Roflumilast—chronic obstructive pulmonary disease	0.00461	0.0156	CcSEcCtD
Benzphetamine—Tremor—Aminophylline—chronic obstructive pulmonary disease	0.00445	0.015	CcSEcCtD
Benzphetamine—Agitation—Aminophylline—chronic obstructive pulmonary disease	0.00436	0.0148	CcSEcCtD
Benzphetamine—Hypersensitivity—Roflumilast—chronic obstructive pulmonary disease	0.00428	0.0145	CcSEcCtD
Benzphetamine—Palpitations—Aminophylline—chronic obstructive pulmonary disease	0.00419	0.0142	CcSEcCtD
Benzphetamine—Sweating—Salbutamol—chronic obstructive pulmonary disease	0.00418	0.0142	CcSEcCtD
Benzphetamine—Diarrhoea—Roflumilast—chronic obstructive pulmonary disease	0.00397	0.0134	CcSEcCtD
Benzphetamine—Palpitations—Tiotropium—chronic obstructive pulmonary disease	0.00395	0.0134	CcSEcCtD
Benzphetamine—Dizziness—Roflumilast—chronic obstructive pulmonary disease	0.00384	0.013	CcSEcCtD
Benzphetamine—Tachycardia—Aminophylline—chronic obstructive pulmonary disease	0.00378	0.0128	CcSEcCtD
Benzphetamine—Anorexia—Aminophylline—chronic obstructive pulmonary disease	0.00369	0.0125	CcSEcCtD
Benzphetamine—Headache—Roflumilast—chronic obstructive pulmonary disease	0.00364	0.0123	CcSEcCtD
Benzphetamine—Tachycardia—Tiotropium—chronic obstructive pulmonary disease	0.00356	0.0121	CcSEcCtD
Benzphetamine—Insomnia—Aminophylline—chronic obstructive pulmonary disease	0.0035	0.0119	CcSEcCtD
Benzphetamine—Nausea—Roflumilast—chronic obstructive pulmonary disease	0.00345	0.0117	CcSEcCtD
Benzphetamine—Dyspepsia—Aminophylline—chronic obstructive pulmonary disease	0.00341	0.0115	CcSEcCtD
Benzphetamine—Tremor—Formoterol—chronic obstructive pulmonary disease	0.00338	0.0115	CcSEcCtD
Benzphetamine—Tremor—Arformoterol—chronic obstructive pulmonary disease	0.00338	0.0115	CcSEcCtD
Benzphetamine—Decreased appetite—Aminophylline—chronic obstructive pulmonary disease	0.00337	0.0114	CcSEcCtD
Benzphetamine—Agitation—Formoterol—chronic obstructive pulmonary disease	0.00332	0.0112	CcSEcCtD
Benzphetamine—Agitation—Arformoterol—chronic obstructive pulmonary disease	0.00332	0.0112	CcSEcCtD
Benzphetamine—Tremor—Montelukast—chronic obstructive pulmonary disease	0.00331	0.0112	CcSEcCtD
Benzphetamine—Insomnia—Tiotropium—chronic obstructive pulmonary disease	0.0033	0.0112	CcSEcCtD
Benzphetamine—Agitation—Montelukast—chronic obstructive pulmonary disease	0.00325	0.011	CcSEcCtD
Benzphetamine—Dyspepsia—Tiotropium—chronic obstructive pulmonary disease	0.00321	0.0109	CcSEcCtD
Benzphetamine—Tremor—Salbutamol—chronic obstructive pulmonary disease	0.00319	0.0108	CcSEcCtD
Benzphetamine—Palpitations—Arformoterol—chronic obstructive pulmonary disease	0.00319	0.0108	CcSEcCtD
Benzphetamine—Palpitations—Formoterol—chronic obstructive pulmonary disease	0.00319	0.0108	CcSEcCtD
Benzphetamine—Gastrointestinal disorder—Tiotropium—chronic obstructive pulmonary disease	0.00315	0.0107	CcSEcCtD
Benzphetamine—Agitation—Salbutamol—chronic obstructive pulmonary disease	0.00313	0.0106	CcSEcCtD
Benzphetamine—Levomethadyl Acetate—CHRNA3—chronic obstructive pulmonary disease	0.00313	0.123	CrCbGaD
Benzphetamine—Palpitations—Montelukast—chronic obstructive pulmonary disease	0.00313	0.0106	CcSEcCtD
Benzphetamine—Urticaria—Aminophylline—chronic obstructive pulmonary disease	0.00308	0.0104	CcSEcCtD
Benzphetamine—Palpitations—Salbutamol—chronic obstructive pulmonary disease	0.00301	0.0102	CcSEcCtD
Benzphetamine—Urticaria—Tiotropium—chronic obstructive pulmonary disease	0.0029	0.00982	CcSEcCtD
Benzphetamine—Tachycardia—Arformoterol—chronic obstructive pulmonary disease	0.00288	0.00974	CcSEcCtD
Benzphetamine—Tachycardia—Formoterol—chronic obstructive pulmonary disease	0.00288	0.00974	CcSEcCtD
Benzphetamine—Hypersensitivity—Aminophylline—chronic obstructive pulmonary disease	0.00285	0.00966	CcSEcCtD
Benzphetamine—Tachycardia—Salbutamol—chronic obstructive pulmonary disease	0.00272	0.00919	CcSEcCtD
Benzphetamine—Hypersensitivity—Tiotropium—chronic obstructive pulmonary disease	0.00269	0.00911	CcSEcCtD
Benzphetamine—Hyperhidrosis—Salbutamol—chronic obstructive pulmonary disease	0.00269	0.00911	CcSEcCtD
Benzphetamine—Insomnia—Arformoterol—chronic obstructive pulmonary disease	0.00267	0.00902	CcSEcCtD
Benzphetamine—Insomnia—Formoterol—chronic obstructive pulmonary disease	0.00267	0.00902	CcSEcCtD
Benzphetamine—Anorexia—Salbutamol—chronic obstructive pulmonary disease	0.00265	0.00898	CcSEcCtD
Benzphetamine—Diarrhoea—Aminophylline—chronic obstructive pulmonary disease	0.00265	0.00897	CcSEcCtD
Benzphetamine—Insomnia—Montelukast—chronic obstructive pulmonary disease	0.00261	0.00884	CcSEcCtD
Benzphetamine—Dyspepsia—Formoterol—chronic obstructive pulmonary disease	0.00259	0.00878	CcSEcCtD
Benzphetamine—Dyspepsia—Arformoterol—chronic obstructive pulmonary disease	0.00259	0.00878	CcSEcCtD
Benzphetamine—Dizziness—Aminophylline—chronic obstructive pulmonary disease	0.00256	0.00867	CcSEcCtD
Benzphetamine—Gastrointestinal disorder—Formoterol—chronic obstructive pulmonary disease	0.00254	0.00861	CcSEcCtD
Benzphetamine—Gastrointestinal disorder—Arformoterol—chronic obstructive pulmonary disease	0.00254	0.00861	CcSEcCtD
Benzphetamine—Dyspepsia—Montelukast—chronic obstructive pulmonary disease	0.00254	0.0086	CcSEcCtD
Benzphetamine—Insomnia—Salbutamol—chronic obstructive pulmonary disease	0.00252	0.00852	CcSEcCtD
Benzphetamine—Gastrointestinal disorder—Montelukast—chronic obstructive pulmonary disease	0.00249	0.00844	CcSEcCtD
Benzphetamine—Dyspepsia—Salbutamol—chronic obstructive pulmonary disease	0.00245	0.00829	CcSEcCtD
Benzphetamine—Headache—Aminophylline—chronic obstructive pulmonary disease	0.00243	0.00821	CcSEcCtD
Benzphetamine—Decreased appetite—Salbutamol—chronic obstructive pulmonary disease	0.00242	0.00819	CcSEcCtD
Benzphetamine—Dizziness—Tiotropium—chronic obstructive pulmonary disease	0.00241	0.00817	CcSEcCtD
Benzphetamine—Gastrointestinal disorder—Salbutamol—chronic obstructive pulmonary disease	0.0024	0.00813	CcSEcCtD
Benzphetamine—Urticaria—Formoterol—chronic obstructive pulmonary disease	0.00234	0.00792	CcSEcCtD
Benzphetamine—Urticaria—Arformoterol—chronic obstructive pulmonary disease	0.00234	0.00792	CcSEcCtD
Benzphetamine—Psychotic disorder—Prednisone—chronic obstructive pulmonary disease	0.0023	0.0078	CcSEcCtD
Benzphetamine—Nausea—Aminophylline—chronic obstructive pulmonary disease	0.0023	0.00779	CcSEcCtD
Benzphetamine—Urticaria—Montelukast—chronic obstructive pulmonary disease	0.00229	0.00776	CcSEcCtD
Benzphetamine—Headache—Tiotropium—chronic obstructive pulmonary disease	0.00229	0.00774	CcSEcCtD
Benzphetamine—Urticaria—Salbutamol—chronic obstructive pulmonary disease	0.00221	0.00748	CcSEcCtD
Benzphetamine—Hypersensitivity—Formoterol—chronic obstructive pulmonary disease	0.00217	0.00735	CcSEcCtD
Benzphetamine—Hypersensitivity—Arformoterol—chronic obstructive pulmonary disease	0.00217	0.00735	CcSEcCtD
Benzphetamine—Nausea—Tiotropium—chronic obstructive pulmonary disease	0.00217	0.00734	CcSEcCtD
Benzphetamine—Hypersensitivity—Montelukast—chronic obstructive pulmonary disease	0.00213	0.0072	CcSEcCtD
Benzphetamine—Hypersensitivity—Salbutamol—chronic obstructive pulmonary disease	0.00205	0.00694	CcSEcCtD
Benzphetamine—Diarrhoea—Formoterol—chronic obstructive pulmonary disease	0.00202	0.00683	CcSEcCtD
Benzphetamine—Diarrhoea—Arformoterol—chronic obstructive pulmonary disease	0.00202	0.00683	CcSEcCtD
Benzphetamine—Diarrhoea—Montelukast—chronic obstructive pulmonary disease	0.00197	0.00668	CcSEcCtD
Benzphetamine—Dizziness—Arformoterol—chronic obstructive pulmonary disease	0.00195	0.0066	CcSEcCtD
Benzphetamine—Dizziness—Formoterol—chronic obstructive pulmonary disease	0.00195	0.0066	CcSEcCtD
Benzphetamine—Dizziness—Montelukast—chronic obstructive pulmonary disease	0.00191	0.00646	CcSEcCtD
Benzphetamine—Diarrhoea—Salbutamol—chronic obstructive pulmonary disease	0.0019	0.00644	CcSEcCtD
Benzphetamine—Headache—Formoterol—chronic obstructive pulmonary disease	0.00185	0.00625	CcSEcCtD
Benzphetamine—Headache—Arformoterol—chronic obstructive pulmonary disease	0.00185	0.00625	CcSEcCtD
Benzphetamine—Dizziness—Salbutamol—chronic obstructive pulmonary disease	0.00184	0.00623	CcSEcCtD
Benzphetamine—Headache—Montelukast—chronic obstructive pulmonary disease	0.00181	0.00612	CcSEcCtD
Benzphetamine—Nausea—Formoterol—chronic obstructive pulmonary disease	0.00175	0.00593	CcSEcCtD
Benzphetamine—Nausea—Arformoterol—chronic obstructive pulmonary disease	0.00175	0.00593	CcSEcCtD
Benzphetamine—Headache—Salbutamol—chronic obstructive pulmonary disease	0.00174	0.0059	CcSEcCtD
Benzphetamine—Nausea—Montelukast—chronic obstructive pulmonary disease	0.00171	0.0058	CcSEcCtD
Benzphetamine—Nausea—Salbutamol—chronic obstructive pulmonary disease	0.00165	0.00559	CcSEcCtD
Benzphetamine—Tachycardia—Prednisolone—chronic obstructive pulmonary disease	0.00156	0.00527	CcSEcCtD
Benzphetamine—Hyperhidrosis—Prednisolone—chronic obstructive pulmonary disease	0.00154	0.00522	CcSEcCtD
Benzphetamine—Insomnia—Prednisolone—chronic obstructive pulmonary disease	0.00144	0.00489	CcSEcCtD
Benzphetamine—Toremifene—CYP1A1—chronic obstructive pulmonary disease	0.00137	0.0539	CrCbGaD
Benzphetamine—Toremifene—CYP1A2—chronic obstructive pulmonary disease	0.00132	0.0519	CrCbGaD
Benzphetamine—Agitation—Prednisone—chronic obstructive pulmonary disease	0.00131	0.00442	CcSEcCtD
Benzphetamine—Urticaria—Prednisolone—chronic obstructive pulmonary disease	0.00127	0.00429	CcSEcCtD
Benzphetamine—Hypersensitivity—Prednisolone—chronic obstructive pulmonary disease	0.00118	0.00398	CcSEcCtD
Benzphetamine—Cyclobenzaprine—CYP1A2—chronic obstructive pulmonary disease	0.00114	0.0449	CrCbGaD
Benzphetamine—Tachycardia—Prednisone—chronic obstructive pulmonary disease	0.00113	0.00383	CcSEcCtD
Benzphetamine—Hyperhidrosis—Prednisone—chronic obstructive pulmonary disease	0.00112	0.00379	CcSEcCtD
Benzphetamine—Anorexia—Prednisone—chronic obstructive pulmonary disease	0.00111	0.00374	CcSEcCtD
Benzphetamine—Dizziness—Prednisolone—chronic obstructive pulmonary disease	0.00106	0.00357	CcSEcCtD
Benzphetamine—Insomnia—Prednisone—chronic obstructive pulmonary disease	0.00105	0.00355	CcSEcCtD
Benzphetamine—CYP3A4—Tamoxifen metabolism—CYP1A2—chronic obstructive pulmonary disease	0.00104	0.00558	CbGpPWpGaD
Benzphetamine—ADRA1A—AMPK Signaling—ADIPOQ—chronic obstructive pulmonary disease	0.00103	0.00553	CbGpPWpGaD
Benzphetamine—Dyspepsia—Prednisone—chronic obstructive pulmonary disease	0.00102	0.00346	CcSEcCtD
Benzphetamine—SLC6A3—Transmission across Chemical Synapses—CHRNA5—chronic obstructive pulmonary disease	0.00102	0.00548	CbGpPWpGaD
Benzphetamine—CYP2B6—Metapathway biotransformation—EPHX1—chronic obstructive pulmonary disease	0.00101	0.00543	CbGpPWpGaD
Benzphetamine—Decreased appetite—Prednisone—chronic obstructive pulmonary disease	0.00101	0.00341	CcSEcCtD
Benzphetamine—Headache—Prednisolone—chronic obstructive pulmonary disease	0.001	0.00338	CcSEcCtD
Benzphetamine—CYP2B6—Cytochrome P450 - arranged by substrate type—CYP1A2—chronic obstructive pulmonary disease	0.000987	0.00531	CbGpPWpGaD
Benzphetamine—CYP2B6—Oxidation by Cytochrome P450—CYP1A2—chronic obstructive pulmonary disease	0.000974	0.00524	CbGpPWpGaD
Benzphetamine—SLC6A3—Monoamine Transport—IL1B—chronic obstructive pulmonary disease	0.000973	0.00523	CbGpPWpGaD
Benzphetamine—SLC6A2—Transmembrane transport of small molecules—TRPV4—chronic obstructive pulmonary disease	0.000971	0.00522	CbGpPWpGaD
Benzphetamine—ADRA2A—Amine ligand-binding receptors—HTR2A—chronic obstructive pulmonary disease	0.000968	0.00521	CbGpPWpGaD
Benzphetamine—SLC6A3—Transmembrane transport of small molecules—ATP2C2—chronic obstructive pulmonary disease	0.000965	0.00519	CbGpPWpGaD
Benzphetamine—SLC6A2—NRF2 pathway—GCLC—chronic obstructive pulmonary disease	0.000965	0.00519	CbGpPWpGaD
Benzphetamine—Cyclobenzaprine—HTR2A—chronic obstructive pulmonary disease	0.000964	0.0379	CrCbGaD
Benzphetamine—Nausea—Prednisolone—chronic obstructive pulmonary disease	0.000948	0.00321	CcSEcCtD
Benzphetamine—CYP3A4—Fatty Acid Omega Oxidation—CYP1A1—chronic obstructive pulmonary disease	0.000938	0.00504	CbGpPWpGaD
Benzphetamine—SLC6A3—NRF2 pathway—SERPINA1—chronic obstructive pulmonary disease	0.000935	0.00503	CbGpPWpGaD
Benzphetamine—Propafenone—CYP1A2—chronic obstructive pulmonary disease	0.000931	0.0366	CrCbGaD
Benzphetamine—Urticaria—Prednisone—chronic obstructive pulmonary disease	0.000921	0.00312	CcSEcCtD
Benzphetamine—SLC6A2—NRF2 pathway—TGFB2—chronic obstructive pulmonary disease	0.000915	0.00492	CbGpPWpGaD
Benzphetamine—CYP3A4—Estrogen metabolism—GSTM1—chronic obstructive pulmonary disease	0.000901	0.00484	CbGpPWpGaD
Benzphetamine—SLC6A2—NRF2 pathway—SLC6A4—chronic obstructive pulmonary disease	0.000897	0.00482	CbGpPWpGaD
Benzphetamine—Selegiline—CYP1A2—chronic obstructive pulmonary disease	0.000885	0.0348	CrCbGaD
Benzphetamine—ADRA1A—Endothelin Pathways—NOS3—chronic obstructive pulmonary disease	0.000863	0.00464	CbGpPWpGaD
Benzphetamine—SLC6A3—Transmembrane transport of small molecules—TRPV4—chronic obstructive pulmonary disease	0.00086	0.00463	CbGpPWpGaD
Benzphetamine—SLC6A3—NRF2 pathway—GCLC—chronic obstructive pulmonary disease	0.000855	0.0046	CbGpPWpGaD
Benzphetamine—Hypersensitivity—Prednisone—chronic obstructive pulmonary disease	0.000854	0.00289	CcSEcCtD
Benzphetamine—CYP3A4—Estrogen metabolism—CYP1A1—chronic obstructive pulmonary disease	0.000854	0.00459	CbGpPWpGaD
Benzphetamine—ADRA2A—Platelet activation, signaling and aggregation—RAPGEF3—chronic obstructive pulmonary disease	0.00084	0.00451	CbGpPWpGaD
Benzphetamine—SLC6A3—Transmission across Chemical Synapses—CHRNA3—chronic obstructive pulmonary disease	0.000832	0.00447	CbGpPWpGaD
Benzphetamine—SLC6A3—NRF2 pathway—TGFB2—chronic obstructive pulmonary disease	0.000811	0.00436	CbGpPWpGaD
Benzphetamine—Amphetamine—SLC6A4—chronic obstructive pulmonary disease	0.000808	0.0318	CrCbGaD
Benzphetamine—CYP2B6—Phase 1 - Functionalization of compounds—CYP1A2—chronic obstructive pulmonary disease	0.0008	0.0043	CbGpPWpGaD
Benzphetamine—SLC6A2—Monoamine Transport—TNF—chronic obstructive pulmonary disease	0.000797	0.00429	CbGpPWpGaD
Benzphetamine—SLC6A3—Dopaminergic Neurogenesis—TGFB1—chronic obstructive pulmonary disease	0.000796	0.00428	CbGpPWpGaD
Benzphetamine—SLC6A3—NRF2 pathway—SLC6A4—chronic obstructive pulmonary disease	0.000795	0.00427	CbGpPWpGaD
Benzphetamine—Diarrhoea—Prednisone—chronic obstructive pulmonary disease	0.000794	0.00269	CcSEcCtD
Benzphetamine—CYP3A4—Xenobiotics—CYP1A1—chronic obstructive pulmonary disease	0.000785	0.00422	CbGpPWpGaD
Benzphetamine—Phenoxybenzamine—ADRB2—chronic obstructive pulmonary disease	0.000782	0.0307	CrCbGaD
Benzphetamine—SLC6A3—Neuronal System—CHRNA5—chronic obstructive pulmonary disease	0.000782	0.0042	CbGpPWpGaD
Benzphetamine—Modafinil—CYP1A2—chronic obstructive pulmonary disease	0.00078	0.0307	CrCbGaD
Benzphetamine—Dizziness—Prednisone—chronic obstructive pulmonary disease	0.000767	0.0026	CcSEcCtD
Benzphetamine—CYP3A4—Tamoxifen metabolism—CYP1A1—chronic obstructive pulmonary disease	0.000755	0.00406	CbGpPWpGaD
Benzphetamine—Methamphetamine—SLC6A4—chronic obstructive pulmonary disease	0.000749	0.0294	CrCbGaD
Benzphetamine—Atomoxetine—SLC6A4—chronic obstructive pulmonary disease	0.000737	0.029	CrCbGaD
Benzphetamine—Headache—Prednisone—chronic obstructive pulmonary disease	0.000727	0.00246	CcSEcCtD
Benzphetamine—CYP2B6—Cytochrome P450 - arranged by substrate type—CYP1A1—chronic obstructive pulmonary disease	0.000717	0.00385	CbGpPWpGaD
Benzphetamine—CYP2B6—Oxidation by Cytochrome P450—CYP1A1—chronic obstructive pulmonary disease	0.000708	0.0038	CbGpPWpGaD
Benzphetamine—CYP3A4—Nuclear Receptors in Lipid Metabolism and Toxicity—CYP1A2—chronic obstructive pulmonary disease	0.000706	0.0038	CbGpPWpGaD
Benzphetamine—SLC6A3—Monoamine Transport—TNF—chronic obstructive pulmonary disease	0.000706	0.0038	CbGpPWpGaD
Benzphetamine—Nausea—Prednisone—chronic obstructive pulmonary disease	0.000689	0.00233	CcSEcCtD
Benzphetamine—SLC6A2—NRF2 pathway—GSTP1—chronic obstructive pulmonary disease	0.000677	0.00364	CbGpPWpGaD
Benzphetamine—SLC6A2—NRF2 pathway—HMOX1—chronic obstructive pulmonary disease	0.000668	0.00359	CbGpPWpGaD
Benzphetamine—ADRA1A—AMPK Signaling—LEP—chronic obstructive pulmonary disease	0.000639	0.00343	CbGpPWpGaD
Benzphetamine—SLC6A3—Neuronal System—CHRNA3—chronic obstructive pulmonary disease	0.000637	0.00342	CbGpPWpGaD
Benzphetamine—SLC6A2—NRF2 pathway—GSTM1—chronic obstructive pulmonary disease	0.000622	0.00334	CbGpPWpGaD
Benzphetamine—Phenprocoumon—ALB—chronic obstructive pulmonary disease	0.00062	0.0244	CrCbGaD
Benzphetamine—Trimipramine—SLC6A4—chronic obstructive pulmonary disease	0.000606	0.0238	CrCbGaD
Benzphetamine—SLC6A3—NRF2 pathway—GSTP1—chronic obstructive pulmonary disease	0.0006	0.00322	CbGpPWpGaD
Benzphetamine—SLC6A3—NRF2 pathway—HMOX1—chronic obstructive pulmonary disease	0.000591	0.00318	CbGpPWpGaD
Benzphetamine—CYP2B6—Phase 1 - Functionalization of compounds—CYP1A1—chronic obstructive pulmonary disease	0.000581	0.00312	CbGpPWpGaD
Benzphetamine—Atomoxetine—HTR2A—chronic obstructive pulmonary disease	0.000566	0.0223	CrCbGaD
Benzphetamine—CYP3A4—Tryptophan metabolism—CYP1A2—chronic obstructive pulmonary disease	0.000555	0.00298	CbGpPWpGaD
Benzphetamine—SLC6A3—NRF2 pathway—GSTM1—chronic obstructive pulmonary disease	0.000551	0.00296	CbGpPWpGaD
Benzphetamine—Tamoxifen—CYP1A1—chronic obstructive pulmonary disease	0.000547	0.0215	CrCbGaD
Benzphetamine—Diphenhydramine—CYP1A2—chronic obstructive pulmonary disease	0.000542	0.0213	CrCbGaD
Benzphetamine—Tamoxifen—CYP1A2—chronic obstructive pulmonary disease	0.000528	0.0207	CrCbGaD
Benzphetamine—Methadone—CYP1A2—chronic obstructive pulmonary disease	0.000523	0.0206	CrCbGaD
Benzphetamine—CYP2B6—Biological oxidations—GSTT1—chronic obstructive pulmonary disease	0.000511	0.00275	CbGpPWpGaD
Benzphetamine—CYP2B6—Biological oxidations—GCLC—chronic obstructive pulmonary disease	0.000505	0.00272	CbGpPWpGaD
Benzphetamine—ADRA2A—Hemostasis—SERPINE2—chronic obstructive pulmonary disease	0.000495	0.00266	CbGpPWpGaD
Benzphetamine—ADRA2A—G alpha (i) signalling events—CXCR2—chronic obstructive pulmonary disease	0.000488	0.00263	CbGpPWpGaD
Benzphetamine—ADRA1A—GPCRs, Class A Rhodopsin-like—CXCR2—chronic obstructive pulmonary disease	0.000488	0.00262	CbGpPWpGaD
Benzphetamine—ADRA2A—Platelet activation, signaling and aggregation—SERPINA1—chronic obstructive pulmonary disease	0.000482	0.00259	CbGpPWpGaD
Benzphetamine—ADRA1A—Calcium Regulation in the Cardiac Cell—ADRB2—chronic obstructive pulmonary disease	0.000475	0.00255	CbGpPWpGaD
Benzphetamine—Promazine—CYP1A2—chronic obstructive pulmonary disease	0.000468	0.0184	CrCbGaD
Benzphetamine—Trimipramine—HTR2A—chronic obstructive pulmonary disease	0.000466	0.0183	CrCbGaD
Benzphetamine—CYP3A4—Metapathway biotransformation—EPHX1—chronic obstructive pulmonary disease	0.000459	0.00247	CbGpPWpGaD
Benzphetamine—ADRA2A—GPCRs, Class A Rhodopsin-like—CXCR2—chronic obstructive pulmonary disease	0.000453	0.00244	CbGpPWpGaD
Benzphetamine—Promethazine—HTR2A—chronic obstructive pulmonary disease	0.000449	0.0176	CrCbGaD
Benzphetamine—CYP3A4—Cytochrome P450 - arranged by substrate type—CYP1A2—chronic obstructive pulmonary disease	0.000448	0.00241	CbGpPWpGaD
Benzphetamine—CYP3A4—Oxidation by Cytochrome P450—CYP1A2—chronic obstructive pulmonary disease	0.000443	0.00238	CbGpPWpGaD
Benzphetamine—ADRA2A—Hemostasis—RAPGEF3—chronic obstructive pulmonary disease	0.000433	0.00233	CbGpPWpGaD
Benzphetamine—CYP2B6—Biological oxidations—CYP1A2—chronic obstructive pulmonary disease	0.000425	0.00228	CbGpPWpGaD
Benzphetamine—CYP2B6—Metapathway biotransformation—CYP1A2—chronic obstructive pulmonary disease	0.000419	0.00225	CbGpPWpGaD
Benzphetamine—ADRA2A—Platelet activation, signaling and aggregation—TGFB2—chronic obstructive pulmonary disease	0.000418	0.00225	CbGpPWpGaD
Benzphetamine—ADRA1A—Class A/1 (Rhodopsin-like receptors)—CXCR2—chronic obstructive pulmonary disease	0.000418	0.00225	CbGpPWpGaD
Benzphetamine—CYP3A4—Tryptophan metabolism—CYP1A1—chronic obstructive pulmonary disease	0.000403	0.00217	CbGpPWpGaD
Benzphetamine—Phenytoin—ALB—chronic obstructive pulmonary disease	0.0004	0.0157	CrCbGaD
Benzphetamine—Promazine—HTR2A—chronic obstructive pulmonary disease	0.000395	0.0155	CrCbGaD
Benzphetamine—ADRA2A—Class A/1 (Rhodopsin-like receptors)—CXCR2—chronic obstructive pulmonary disease	0.000388	0.00209	CbGpPWpGaD
Benzphetamine—SLC18A2—SLC-mediated transmembrane transport—ALB—chronic obstructive pulmonary disease	0.000375	0.00202	CbGpPWpGaD
Benzphetamine—CYP3A4—Phase 1 - Functionalization of compounds—CYP1A2—chronic obstructive pulmonary disease	0.000364	0.00195	CbGpPWpGaD
Benzphetamine—CYP2B6—Biological oxidations—GSTP1—chronic obstructive pulmonary disease	0.000354	0.00191	CbGpPWpGaD
Benzphetamine—ADRA1A—G alpha (q) signalling events—EDN1—chronic obstructive pulmonary disease	0.000354	0.0019	CbGpPWpGaD
Benzphetamine—CYP2B6—Metapathway biotransformation—GSTP1—chronic obstructive pulmonary disease	0.00035	0.00188	CbGpPWpGaD
Benzphetamine—CYP3A4—Cytochrome P450 - arranged by substrate type—CYP1A1—chronic obstructive pulmonary disease	0.000326	0.00175	CbGpPWpGaD
Benzphetamine—CYP2B6—Biological oxidations—GSTM1—chronic obstructive pulmonary disease	0.000326	0.00175	CbGpPWpGaD
Benzphetamine—CYP3A4—Oxidation by Cytochrome P450—CYP1A1—chronic obstructive pulmonary disease	0.000322	0.00173	CbGpPWpGaD
Benzphetamine—CYP2B6—Metapathway biotransformation—GSTM1—chronic obstructive pulmonary disease	0.000321	0.00173	CbGpPWpGaD
Benzphetamine—ADRA1A—GPCR ligand binding—CXCR2—chronic obstructive pulmonary disease	0.000318	0.00171	CbGpPWpGaD
Benzphetamine—SLC18A2—Transmembrane transport of small molecules—HMOX1—chronic obstructive pulmonary disease	0.000318	0.00171	CbGpPWpGaD
Benzphetamine—ADRA1A—Gastrin-CREB signalling pathway via PKC and MAPK—EDN1—chronic obstructive pulmonary disease	0.000316	0.0017	CbGpPWpGaD
Benzphetamine—ADRA1A—G alpha (q) signalling events—HTR2A—chronic obstructive pulmonary disease	0.00031	0.00166	CbGpPWpGaD
Benzphetamine—CYP2B6—Biological oxidations—CYP1A1—chronic obstructive pulmonary disease	0.000309	0.00166	CbGpPWpGaD
Benzphetamine—ADRA1A—GPCRs, Class A Rhodopsin-like—ADRB2—chronic obstructive pulmonary disease	0.000306	0.00165	CbGpPWpGaD
Benzphetamine—CYP2B6—Metapathway biotransformation—CYP1A1—chronic obstructive pulmonary disease	0.000305	0.00164	CbGpPWpGaD
Benzphetamine—ADRA2A—GPCR ligand binding—CXCR2—chronic obstructive pulmonary disease	0.000296	0.00159	CbGpPWpGaD
Benzphetamine—ADRA2A—GPCRs, Class A Rhodopsin-like—ADRB2—chronic obstructive pulmonary disease	0.000284	0.00153	CbGpPWpGaD
Benzphetamine—ADRA1A—Gastrin-CREB signalling pathway via PKC and MAPK—HTR2A—chronic obstructive pulmonary disease	0.000277	0.00149	CbGpPWpGaD
Benzphetamine—ADRA2A—Metabolism—APIP—chronic obstructive pulmonary disease	0.000265	0.00142	CbGpPWpGaD
Benzphetamine—CYP3A4—Phase 1 - Functionalization of compounds—CYP1A1—chronic obstructive pulmonary disease	0.000264	0.00142	CbGpPWpGaD
Benzphetamine—ADRA1A—Class A/1 (Rhodopsin-like receptors)—ADRB2—chronic obstructive pulmonary disease	0.000262	0.00141	CbGpPWpGaD
Benzphetamine—ADRA1A—Signaling Pathways—FAM13A—chronic obstructive pulmonary disease	0.000261	0.0014	CbGpPWpGaD
Benzphetamine—ADRA1A—AMPK Signaling—TP53—chronic obstructive pulmonary disease	0.000261	0.0014	CbGpPWpGaD
Benzphetamine—SLC6A2—NRF2 pathway—TGFB1—chronic obstructive pulmonary disease	0.000254	0.00136	CbGpPWpGaD
Benzphetamine—SLC6A2—SLC-mediated transmembrane transport—ALB—chronic obstructive pulmonary disease	0.000253	0.00136	CbGpPWpGaD
Benzphetamine—POR—respiratory system—chronic obstructive pulmonary disease	0.000249	0.128	CbGeAlD
Benzphetamine—ADRA2A—Hemostasis—SERPINA1—chronic obstructive pulmonary disease	0.000249	0.00134	CbGpPWpGaD
Benzphetamine—CYP2B6—Metabolism—APIP—chronic obstructive pulmonary disease	0.000248	0.00134	CbGpPWpGaD
Benzphetamine—ADRA2A—Class A/1 (Rhodopsin-like receptors)—ADRB2—chronic obstructive pulmonary disease	0.000244	0.00131	CbGpPWpGaD
Benzphetamine—ADRA2A—Signaling Pathways—FAM13A—chronic obstructive pulmonary disease	0.000242	0.0013	CbGpPWpGaD
Benzphetamine—ADRA1A—GPCRs, Class A Rhodopsin-like—HTR2A—chronic obstructive pulmonary disease	0.000239	0.00129	CbGpPWpGaD
Benzphetamine—ADRA1A—Class A/1 (Rhodopsin-like receptors)—EDN1—chronic obstructive pulmonary disease	0.000234	0.00126	CbGpPWpGaD
Benzphetamine—CYP3A4—Biological oxidations—GSTT1—chronic obstructive pulmonary disease	0.000232	0.00125	CbGpPWpGaD
Benzphetamine—CYP3A4—Biological oxidations—GCLC—chronic obstructive pulmonary disease	0.00023	0.00123	CbGpPWpGaD
Benzphetamine—SLC6A3—NRF2 pathway—TGFB1—chronic obstructive pulmonary disease	0.000225	0.00121	CbGpPWpGaD
Benzphetamine—SLC6A3—SLC-mediated transmembrane transport—ALB—chronic obstructive pulmonary disease	0.000224	0.0012	CbGpPWpGaD
Benzphetamine—ADRA1A—GPCR downstream signaling—PDE4A—chronic obstructive pulmonary disease	0.000223	0.0012	CbGpPWpGaD
Benzphetamine—ADRA2A—GPCRs, Class A Rhodopsin-like—HTR2A—chronic obstructive pulmonary disease	0.000222	0.00119	CbGpPWpGaD
Benzphetamine—ADRA2A—Class A/1 (Rhodopsin-like receptors)—EDN1—chronic obstructive pulmonary disease	0.000218	0.00117	CbGpPWpGaD
Benzphetamine—ADRA2A—Hemostasis—TGFB2—chronic obstructive pulmonary disease	0.000216	0.00116	CbGpPWpGaD
Benzphetamine—SLC6A2—Transmembrane transport of small molecules—HMOX1—chronic obstructive pulmonary disease	0.000214	0.00115	CbGpPWpGaD
Benzphetamine—ADRA2A—GPCR downstream signaling—PDE4A—chronic obstructive pulmonary disease	0.000207	0.00111	CbGpPWpGaD
Benzphetamine—ADRA1A—Class A/1 (Rhodopsin-like receptors)—HTR2A—chronic obstructive pulmonary disease	0.000205	0.0011	CbGpPWpGaD
Benzphetamine—POR—bronchus—chronic obstructive pulmonary disease	0.000205	0.105	CbGeAlD
Benzphetamine—ADRA1A—Signaling by GPCR—PDE4A—chronic obstructive pulmonary disease	0.000203	0.00109	CbGpPWpGaD
Benzphetamine—ADRA1A—GPCR ligand binding—ADRB2—chronic obstructive pulmonary disease	0.0002	0.00107	CbGpPWpGaD
Benzphetamine—ADRA2A—Hemostasis—HDAC2—chronic obstructive pulmonary disease	0.000193	0.00104	CbGpPWpGaD
Benzphetamine—CYP3A4—Biological oxidations—CYP1A2—chronic obstructive pulmonary disease	0.000193	0.00104	CbGpPWpGaD
Benzphetamine—SLC18A2—Transmembrane transport of small molecules—ALB—chronic obstructive pulmonary disease	0.000191	0.00103	CbGpPWpGaD
Benzphetamine—CYP3A4—Metapathway biotransformation—CYP1A2—chronic obstructive pulmonary disease	0.00019	0.00102	CbGpPWpGaD
Benzphetamine—ADRA2A—Class A/1 (Rhodopsin-like receptors)—HTR2A—chronic obstructive pulmonary disease	0.00019	0.00102	CbGpPWpGaD
Benzphetamine—SLC6A3—Transmembrane transport of small molecules—HMOX1—chronic obstructive pulmonary disease	0.000189	0.00102	CbGpPWpGaD
Benzphetamine—ADRA2A—Signaling by GPCR—PDE4A—chronic obstructive pulmonary disease	0.000188	0.00101	CbGpPWpGaD
Benzphetamine—ADRA2A—GPCR ligand binding—ADRB2—chronic obstructive pulmonary disease	0.000186	0.000997	CbGpPWpGaD
Benzphetamine—POR—trachea—chronic obstructive pulmonary disease	0.000184	0.0945	CbGeAlD
Benzphetamine—ADRA2A—Platelet activation, signaling and aggregation—SERPINE1—chronic obstructive pulmonary disease	0.000184	0.000987	CbGpPWpGaD
Benzphetamine—ADRA2A—Platelet activation, signaling and aggregation—ALB—chronic obstructive pulmonary disease	0.000183	0.000985	CbGpPWpGaD
Benzphetamine—ADRA1A—GPCR downstream signaling—CXCR2—chronic obstructive pulmonary disease	0.00018	0.000967	CbGpPWpGaD
Benzphetamine—SLC6A3—respiratory system—chronic obstructive pulmonary disease	0.00018	0.0922	CbGeAlD
Benzphetamine—ADRA1A—GPCR ligand binding—EDN1—chronic obstructive pulmonary disease	0.000178	0.000959	CbGpPWpGaD
Benzphetamine—ADRA2A—Metabolism—RAPGEF3—chronic obstructive pulmonary disease	0.000176	0.000944	CbGpPWpGaD
Benzphetamine—ADRA2A—Hemostasis—PLAUR—chronic obstructive pulmonary disease	0.000174	0.000937	CbGpPWpGaD
Benzphetamine—ADRA2A—Metabolism—GC—chronic obstructive pulmonary disease	0.000171	0.000918	CbGpPWpGaD
Benzphetamine—ADRA2A—GPCR downstream signaling—CXCR2—chronic obstructive pulmonary disease	0.000167	0.000898	CbGpPWpGaD
Benzphetamine—ADRA2A—GPCR ligand binding—EDN1—chronic obstructive pulmonary disease	0.000166	0.000891	CbGpPWpGaD
Benzphetamine—CYP2B6—Metabolism—RAPGEF3—chronic obstructive pulmonary disease	0.000165	0.000885	CbGpPWpGaD
Benzphetamine—ADRA1A—Signaling by GPCR—CXCR2—chronic obstructive pulmonary disease	0.000163	0.000878	CbGpPWpGaD
Benzphetamine—CYP3A4—Biological oxidations—GSTP1—chronic obstructive pulmonary disease	0.000161	0.000866	CbGpPWpGaD
Benzphetamine—CYP2B6—Metabolism—GC—chronic obstructive pulmonary disease	0.00016	0.00086	CbGpPWpGaD
Benzphetamine—CYP3A4—Metapathway biotransformation—GSTP1—chronic obstructive pulmonary disease	0.000159	0.000854	CbGpPWpGaD
Benzphetamine—ADRA2A—Metabolism—ALDH7A1—chronic obstructive pulmonary disease	0.000159	0.000853	CbGpPWpGaD
Benzphetamine—ADRA1A—Signaling Pathways—RAPGEF3—chronic obstructive pulmonary disease	0.000158	0.000849	CbGpPWpGaD
Benzphetamine—ADRA1A—GPCR ligand binding—HTR2A—chronic obstructive pulmonary disease	0.000156	0.000839	CbGpPWpGaD
Benzphetamine—ADRA2A—Signaling by GPCR—CXCR2—chronic obstructive pulmonary disease	0.000152	0.000816	CbGpPWpGaD
Benzphetamine—CYP2B6—Metabolism—ALDH7A1—chronic obstructive pulmonary disease	0.000149	0.0008	CbGpPWpGaD
Benzphetamine—CYP3A4—Biological oxidations—GSTM1—chronic obstructive pulmonary disease	0.000148	0.000796	CbGpPWpGaD
Benzphetamine—ADRA2A—G alpha (i) signalling events—CXCL8—chronic obstructive pulmonary disease	0.000148	0.000796	CbGpPWpGaD
Benzphetamine—ADRA2A—Signaling Pathways—RAPGEF3—chronic obstructive pulmonary disease	0.000147	0.000789	CbGpPWpGaD
Benzphetamine—CYP3A4—Metapathway biotransformation—GSTM1—chronic obstructive pulmonary disease	0.000146	0.000785	CbGpPWpGaD
Benzphetamine—ADRA2A—GPCR ligand binding—HTR2A—chronic obstructive pulmonary disease	0.000145	0.00078	CbGpPWpGaD
Benzphetamine—SLC6A2—respiratory system—chronic obstructive pulmonary disease	0.000145	0.0744	CbGeAlD
Benzphetamine—CYP3A4—Biological oxidations—CYP1A1—chronic obstructive pulmonary disease	0.00014	0.000754	CbGpPWpGaD
Benzphetamine—CYP3A4—Metapathway biotransformation—CYP1A1—chronic obstructive pulmonary disease	0.000138	0.000744	CbGpPWpGaD
Benzphetamine—POR—lung—chronic obstructive pulmonary disease	0.000132	0.0679	CbGeAlD
Benzphetamine—SLC6A2—Transmembrane transport of small molecules—ALB—chronic obstructive pulmonary disease	0.000128	0.00069	CbGpPWpGaD
Benzphetamine—ADRA1A—Class A/1 (Rhodopsin-like receptors)—CXCL8—chronic obstructive pulmonary disease	0.000127	0.000681	CbGpPWpGaD
Benzphetamine—ADRA2A—Platelet activation, signaling and aggregation—VEGFA—chronic obstructive pulmonary disease	0.000126	0.000679	CbGpPWpGaD
Benzphetamine—SLC18A2—lung—chronic obstructive pulmonary disease	0.000126	0.0647	CbGeAlD
Benzphetamine—ADRA1A—Gastrin-CREB signalling pathway via PKC and MAPK—EGFR—chronic obstructive pulmonary disease	0.000125	0.000672	CbGpPWpGaD
Benzphetamine—ADRA2A—Hemostasis—MMP1—chronic obstructive pulmonary disease	0.000125	0.00067	CbGpPWpGaD
Benzphetamine—ADRA2A—Hemostasis—PLAU—chronic obstructive pulmonary disease	0.000122	0.000657	CbGpPWpGaD
Benzphetamine—ADRA1A—Signaling Pathways—PDE4A—chronic obstructive pulmonary disease	0.00012	0.000643	CbGpPWpGaD
Benzphetamine—ADRA2A—Class A/1 (Rhodopsin-like receptors)—CXCL8—chronic obstructive pulmonary disease	0.000118	0.000633	CbGpPWpGaD
Benzphetamine—ADRA2A—Platelet activation, signaling and aggregation—TGFB1—chronic obstructive pulmonary disease	0.000116	0.000623	CbGpPWpGaD
Benzphetamine—SLC6A3—Transmembrane transport of small molecules—ALB—chronic obstructive pulmonary disease	0.000114	0.000611	CbGpPWpGaD
Benzphetamine—CYP3A4—Metabolism—APIP—chronic obstructive pulmonary disease	0.000113	0.000607	CbGpPWpGaD
Benzphetamine—ADRA1A—GPCR downstream signaling—ADRB2—chronic obstructive pulmonary disease	0.000113	0.000607	CbGpPWpGaD
Benzphetamine—ADRA2A—Hemostasis—NOS2—chronic obstructive pulmonary disease	0.000112	0.000604	CbGpPWpGaD
Benzphetamine—ADRA2A—Signaling Pathways—PDE4A—chronic obstructive pulmonary disease	0.000111	0.000598	CbGpPWpGaD
Benzphetamine—CYP2B6—respiratory system—chronic obstructive pulmonary disease	0.000107	0.0548	CbGeAlD
Benzphetamine—ADRA2A—GPCR downstream signaling—ADRB2—chronic obstructive pulmonary disease	0.000105	0.000564	CbGpPWpGaD
Benzphetamine—ADRA1A—Signaling by GPCR—ADRB2—chronic obstructive pulmonary disease	0.000102	0.000551	CbGpPWpGaD
Benzphetamine—ADRA1A—GPCR downstream signaling—EDN1—chronic obstructive pulmonary disease	0.000101	0.000542	CbGpPWpGaD
Benzphetamine—ADRA1A—Signaling Pathways—CXCR2—chronic obstructive pulmonary disease	9.65e-05	0.000519	CbGpPWpGaD
Benzphetamine—ADRA1A—GPCR ligand binding—CXCL8—chronic obstructive pulmonary disease	9.64e-05	0.000518	CbGpPWpGaD
Benzphetamine—ADRA1A—Gastrin-CREB signalling pathway via PKC and MAPK—IL6—chronic obstructive pulmonary disease	9.61e-05	0.000516	CbGpPWpGaD
Benzphetamine—SLC6A3—lung—chronic obstructive pulmonary disease	9.53e-05	0.0489	CbGeAlD
Benzphetamine—ADRA2A—Signaling by GPCR—ADRB2—chronic obstructive pulmonary disease	9.52e-05	0.000512	CbGpPWpGaD
Benzphetamine—ADRA2A—Hemostasis—SERPINE1—chronic obstructive pulmonary disease	9.46e-05	0.000509	CbGpPWpGaD
Benzphetamine—ADRA2A—Hemostasis—ALB—chronic obstructive pulmonary disease	9.44e-05	0.000508	CbGpPWpGaD
Benzphetamine—ADRA2A—GPCR downstream signaling—EDN1—chronic obstructive pulmonary disease	9.37e-05	0.000504	CbGpPWpGaD
Benzphetamine—ADRA2A—Metabolism—GSTT1—chronic obstructive pulmonary disease	9.33e-05	0.000501	CbGpPWpGaD
Benzphetamine—ADRA2A—Metabolism—GCLC—chronic obstructive pulmonary disease	9.22e-05	0.000496	CbGpPWpGaD
Benzphetamine—ADRA1A—Signaling by GPCR—EDN1—chronic obstructive pulmonary disease	9.16e-05	0.000492	CbGpPWpGaD
Benzphetamine—ADRA2A—Hemostasis—NOS3—chronic obstructive pulmonary disease	9.03e-05	0.000486	CbGpPWpGaD
Benzphetamine—ADRA2A—connective tissue—chronic obstructive pulmonary disease	9.01e-05	0.0463	CbGeAlD
Benzphetamine—ADRA2A—Signaling Pathways—CXCR2—chronic obstructive pulmonary disease	8.97e-05	0.000482	CbGpPWpGaD
Benzphetamine—ADRA2A—GPCR ligand binding—CXCL8—chronic obstructive pulmonary disease	8.96e-05	0.000482	CbGpPWpGaD
Benzphetamine—ADRA1A—GPCR downstream signaling—HTR2A—chronic obstructive pulmonary disease	8.82e-05	0.000474	CbGpPWpGaD
Benzphetamine—CYP2B6—bronchus—chronic obstructive pulmonary disease	8.78e-05	0.0451	CbGeAlD
Benzphetamine—CYP2B6—Metabolism—GSTT1—chronic obstructive pulmonary disease	8.74e-05	0.00047	CbGpPWpGaD
Benzphetamine—CYP2B6—Metabolism—GCLC—chronic obstructive pulmonary disease	8.64e-05	0.000465	CbGpPWpGaD
Benzphetamine—ADRA2A—Signaling by GPCR—EDN1—chronic obstructive pulmonary disease	8.51e-05	0.000457	CbGpPWpGaD
Benzphetamine—ADRA2A—bronchus—chronic obstructive pulmonary disease	8.42e-05	0.0433	CbGeAlD
Benzphetamine—ADRA2A—Metabolism—CTGF—chronic obstructive pulmonary disease	8.41e-05	0.000452	CbGpPWpGaD
Benzphetamine—ADRA2A—GPCR downstream signaling—HTR2A—chronic obstructive pulmonary disease	8.2e-05	0.000441	CbGpPWpGaD
Benzphetamine—ADRA1A—Signaling by GPCR—HTR2A—chronic obstructive pulmonary disease	8.01e-05	0.000431	CbGpPWpGaD
Benzphetamine—CYP2B6—Metabolism—CTGF—chronic obstructive pulmonary disease	7.89e-05	0.000424	CbGpPWpGaD
Benzphetamine—ADRA2A—Metabolism—CYP1A2—chronic obstructive pulmonary disease	7.75e-05	0.000417	CbGpPWpGaD
Benzphetamine—SLC6A2—lung—chronic obstructive pulmonary disease	7.69e-05	0.0395	CbGeAlD
Benzphetamine—ADRA2A—trachea—chronic obstructive pulmonary disease	7.56e-05	0.0388	CbGeAlD
Benzphetamine—CYP3A4—Metabolism—RAPGEF3—chronic obstructive pulmonary disease	7.48e-05	0.000402	CbGpPWpGaD
Benzphetamine—ADRA2A—Signaling by GPCR—HTR2A—chronic obstructive pulmonary disease	7.44e-05	0.0004	CbGpPWpGaD
Benzphetamine—CYP3A4—Metabolism—GC—chronic obstructive pulmonary disease	7.27e-05	0.000391	CbGpPWpGaD
Benzphetamine—CYP2B6—Metabolism—CYP1A2—chronic obstructive pulmonary disease	7.27e-05	0.000391	CbGpPWpGaD
Benzphetamine—ADRA1A—Signaling Pathways—HDAC2—chronic obstructive pulmonary disease	7.06e-05	0.000379	CbGpPWpGaD
Benzphetamine—CYP3A4—Metabolism—ALDH7A1—chronic obstructive pulmonary disease	6.76e-05	0.000364	CbGpPWpGaD
Benzphetamine—ADRA1A—Signaling Pathways—KL—chronic obstructive pulmonary disease	6.56e-05	0.000353	CbGpPWpGaD
Benzphetamine—ADRA2A—Signaling Pathways—HDAC2—chronic obstructive pulmonary disease	6.56e-05	0.000352	CbGpPWpGaD
Benzphetamine—ADRA2A—Hemostasis—VEGFA—chronic obstructive pulmonary disease	6.51e-05	0.00035	CbGpPWpGaD
Benzphetamine—ADRA2A—Metabolism—GSTP1—chronic obstructive pulmonary disease	6.47e-05	0.000348	CbGpPWpGaD
Benzphetamine—ADRA2A—Metabolism—HMOX1—chronic obstructive pulmonary disease	6.38e-05	0.000343	CbGpPWpGaD
Benzphetamine—ADRA2A—Signaling Pathways—KL—chronic obstructive pulmonary disease	6.09e-05	0.000328	CbGpPWpGaD
Benzphetamine—CYP2B6—Metabolism—GSTP1—chronic obstructive pulmonary disease	6.06e-05	0.000326	CbGpPWpGaD
Benzphetamine—ADRA1A—Signaling Pathways—ADRB2—chronic obstructive pulmonary disease	6.05e-05	0.000325	CbGpPWpGaD
Benzphetamine—CYP2B6—Metabolism—HMOX1—chronic obstructive pulmonary disease	5.98e-05	0.000321	CbGpPWpGaD
Benzphetamine—ADRA2A—Hemostasis—TGFB1—chronic obstructive pulmonary disease	5.97e-05	0.000321	CbGpPWpGaD
Benzphetamine—ADRA2A—Metabolism—GSTM1—chronic obstructive pulmonary disease	5.94e-05	0.000319	CbGpPWpGaD
Benzphetamine—CYP2B6—lung—chronic obstructive pulmonary disease	5.67e-05	0.0291	CbGeAlD
Benzphetamine—ADRA2A—Metabolism—CYP1A1—chronic obstructive pulmonary disease	5.63e-05	0.000303	CbGpPWpGaD
Benzphetamine—ADRA2A—Signaling Pathways—ADRB2—chronic obstructive pulmonary disease	5.62e-05	0.000302	CbGpPWpGaD
Benzphetamine—CYP2B6—Metabolism—GSTM1—chronic obstructive pulmonary disease	5.57e-05	0.000299	CbGpPWpGaD
Benzphetamine—ADRA1A—GPCR downstream signaling—CXCL8—chronic obstructive pulmonary disease	5.45e-05	0.000293	CbGpPWpGaD
Benzphetamine—ADRA2A—lung—chronic obstructive pulmonary disease	5.44e-05	0.0279	CbGeAlD
Benzphetamine—ADRA1A—Signaling Pathways—EDN1—chronic obstructive pulmonary disease	5.41e-05	0.000291	CbGpPWpGaD
Benzphetamine—CYP2B6—Metabolism—CYP1A1—chronic obstructive pulmonary disease	5.28e-05	0.000284	CbGpPWpGaD
Benzphetamine—ADRA2A—GPCR downstream signaling—CXCL8—chronic obstructive pulmonary disease	5.06e-05	0.000272	CbGpPWpGaD
Benzphetamine—ADRA2A—Signaling Pathways—EDN1—chronic obstructive pulmonary disease	5.03e-05	0.00027	CbGpPWpGaD
Benzphetamine—ADRA1A—Signaling by GPCR—CXCL8—chronic obstructive pulmonary disease	4.95e-05	0.000266	CbGpPWpGaD
Benzphetamine—ADRA2A—Hemostasis—TP53—chronic obstructive pulmonary disease	4.92e-05	0.000264	CbGpPWpGaD
Benzphetamine—ADRA1A—Signaling Pathways—ERBB3—chronic obstructive pulmonary disease	4.92e-05	0.000264	CbGpPWpGaD
Benzphetamine—ADRA1A—Signaling Pathways—HTR2A—chronic obstructive pulmonary disease	4.73e-05	0.000254	CbGpPWpGaD
Benzphetamine—ADRA2A—Signaling by GPCR—CXCL8—chronic obstructive pulmonary disease	4.6e-05	0.000247	CbGpPWpGaD
Benzphetamine—ADRA2A—Signaling Pathways—ERBB3—chronic obstructive pulmonary disease	4.57e-05	0.000246	CbGpPWpGaD
Benzphetamine—ADRA1A—Signaling Pathways—LEP—chronic obstructive pulmonary disease	4.4e-05	0.000236	CbGpPWpGaD
Benzphetamine—ADRA2A—Signaling Pathways—HTR2A—chronic obstructive pulmonary disease	4.4e-05	0.000236	CbGpPWpGaD
Benzphetamine—ADRA2A—Signaling Pathways—LEP—chronic obstructive pulmonary disease	4.09e-05	0.00022	CbGpPWpGaD
Benzphetamine—CYP3A4—Metabolism—GSTT1—chronic obstructive pulmonary disease	3.97e-05	0.000214	CbGpPWpGaD
Benzphetamine—CYP3A4—Metabolism—GCLC—chronic obstructive pulmonary disease	3.93e-05	0.000211	CbGpPWpGaD
Benzphetamine—ADRA2A—Metabolism—ALB—chronic obstructive pulmonary disease	3.83e-05	0.000206	CbGpPWpGaD
Benzphetamine—ADRA2A—Metabolism—NOS3—chronic obstructive pulmonary disease	3.66e-05	0.000197	CbGpPWpGaD
Benzphetamine—ADRA1A—Signaling by GPCR—EGFR—chronic obstructive pulmonary disease	3.62e-05	0.000194	CbGpPWpGaD
Benzphetamine—CYP2B6—Metabolism—ALB—chronic obstructive pulmonary disease	3.59e-05	0.000193	CbGpPWpGaD
Benzphetamine—CYP3A4—Metabolism—CTGF—chronic obstructive pulmonary disease	3.58e-05	0.000193	CbGpPWpGaD
Benzphetamine—ADRA1A—Signaling Pathways—SERPINE1—chronic obstructive pulmonary disease	3.45e-05	0.000186	CbGpPWpGaD
Benzphetamine—CYP2B6—Metabolism—NOS3—chronic obstructive pulmonary disease	3.43e-05	0.000185	CbGpPWpGaD
Benzphetamine—ADRA2A—Signaling by GPCR—EGFR—chronic obstructive pulmonary disease	3.36e-05	0.000181	CbGpPWpGaD
Benzphetamine—CYP3A4—Metabolism—CYP1A2—chronic obstructive pulmonary disease	3.3e-05	0.000178	CbGpPWpGaD
Benzphetamine—ADRA1A—Signaling Pathways—NOS3—chronic obstructive pulmonary disease	3.3e-05	0.000177	CbGpPWpGaD
Benzphetamine—ADRA2A—Signaling Pathways—SERPINE1—chronic obstructive pulmonary disease	3.21e-05	0.000172	CbGpPWpGaD
Benzphetamine—ADRA2A—Signaling Pathways—NOS3—chronic obstructive pulmonary disease	3.06e-05	0.000165	CbGpPWpGaD
Benzphetamine—ADRA1A—Signaling Pathways—CXCL8—chronic obstructive pulmonary disease	2.92e-05	0.000157	CbGpPWpGaD
Benzphetamine—ADRA1A—Signaling by GPCR—IL6—chronic obstructive pulmonary disease	2.78e-05	0.000149	CbGpPWpGaD
Benzphetamine—CYP3A4—Metabolism—GSTP1—chronic obstructive pulmonary disease	2.75e-05	0.000148	CbGpPWpGaD
Benzphetamine—CYP3A4—Metabolism—HMOX1—chronic obstructive pulmonary disease	2.72e-05	0.000146	CbGpPWpGaD
Benzphetamine—ADRA2A—Signaling Pathways—CXCL8—chronic obstructive pulmonary disease	2.72e-05	0.000146	CbGpPWpGaD
Benzphetamine—ADRA1A—Signaling Pathways—MMP9—chronic obstructive pulmonary disease	2.64e-05	0.000142	CbGpPWpGaD
Benzphetamine—ADRA2A—Signaling by GPCR—IL6—chronic obstructive pulmonary disease	2.58e-05	0.000139	CbGpPWpGaD
Benzphetamine—CYP3A4—Metabolism—GSTM1—chronic obstructive pulmonary disease	2.53e-05	0.000136	CbGpPWpGaD
Benzphetamine—ADRA2A—Signaling Pathways—MMP9—chronic obstructive pulmonary disease	2.46e-05	0.000132	CbGpPWpGaD
Benzphetamine—CYP3A4—Metabolism—CYP1A1—chronic obstructive pulmonary disease	2.4e-05	0.000129	CbGpPWpGaD
Benzphetamine—ADRA1A—Signaling Pathways—VEGFA—chronic obstructive pulmonary disease	2.37e-05	0.000128	CbGpPWpGaD
Benzphetamine—ADRA2A—Signaling Pathways—VEGFA—chronic obstructive pulmonary disease	2.21e-05	0.000119	CbGpPWpGaD
Benzphetamine—ADRA1A—Signaling Pathways—TGFB1—chronic obstructive pulmonary disease	2.18e-05	0.000117	CbGpPWpGaD
Benzphetamine—ADRA1A—Signaling Pathways—EGFR—chronic obstructive pulmonary disease	2.14e-05	0.000115	CbGpPWpGaD
Benzphetamine—ADRA2A—Signaling Pathways—TGFB1—chronic obstructive pulmonary disease	2.02e-05	0.000109	CbGpPWpGaD
Benzphetamine—ADRA2A—Signaling Pathways—EGFR—chronic obstructive pulmonary disease	1.99e-05	0.000107	CbGpPWpGaD
Benzphetamine—ADRA1A—Signaling Pathways—TP53—chronic obstructive pulmonary disease	1.79e-05	9.64e-05	CbGpPWpGaD
Benzphetamine—ADRA2A—Signaling Pathways—TP53—chronic obstructive pulmonary disease	1.67e-05	8.96e-05	CbGpPWpGaD
Benzphetamine—ADRA1A—Signaling Pathways—IL6—chronic obstructive pulmonary disease	1.64e-05	8.83e-05	CbGpPWpGaD
Benzphetamine—CYP3A4—Metabolism—ALB—chronic obstructive pulmonary disease	1.63e-05	8.77e-05	CbGpPWpGaD
Benzphetamine—CYP3A4—Metabolism—NOS3—chronic obstructive pulmonary disease	1.56e-05	8.39e-05	CbGpPWpGaD
Benzphetamine—ADRA2A—Signaling Pathways—IL6—chronic obstructive pulmonary disease	1.53e-05	8.2e-05	CbGpPWpGaD
